Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Stocks Rally Sharply on Positive US Labor Market News

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +2.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.76%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +3.06%. US stocks on Thursday settled sharply higher. Stocks rallied Thursday after US weekly initial...

Stock Market Today: Stocks Rally as Recession Fears Ease

Stock Market Today: Stocks Rally as Recession Fears Ease

Initial jobless claims fell more than expected last week, which helped calm fears of a slowing labor market.

Stocks Rally as Economic Concerns Ease and Chip Stocks Climb

Stocks Rally as Economic Concerns Ease and Chip Stocks Climb

The S&P 500 Index ($SPX ) (SPY ) today is up +1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.24%. US stocks are trading higher today after US weekly initial unemployment claims fell more...

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Eli Lilly's Weight-Loss Drugs Fuel Beat-And-Raise Quarter

Eli Lilly stock is surging after the pharma giant beat Q2 estimates and lifted its full-year outlook. Here's what you need to know.

Stocks Climb as US Weekly Jobless Claims Ease Economic Concerns

The S&P 500 Index ($SPX ) (SPY ) today is up +0.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.10%. US stocks are trading higher today after US weekly initial unemployment claims fell more...

Dow Jones Rallies 500 Points On Surprise Jobless Claims; Dutch Bros Plunges On Earnings (Live Coverage)

Stock Market Today: The Dow Jones rallied 500 points Thursday on a big drop in weekly jobless claims. Dutch Bros plunged on earnings.

Investors Business Daily

Eli Lilly Surges 10% After Diabetes, Weight-Loss Sales Wallop Expectations

Eli Lilly stock rocketed Thursday after its diabetes and weight-loss drugs walloped expectations, leading to a guidance hike.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Futures Await Key Economic Data After Nvidia-Led Reversal; 7 Earnings Movers

Dow Jones Futures Await Key Economic Data After Nvidia-Led Reversal; 7 Earnings Movers

Key economic data is on tap after Nvidia helped lead Wednesday's downside stock market reversal.

Investors Business Daily

Novo Nordisk cuts profit outlook after weaker sales of weight-loss drug Wegovy

Novo Nordisk cuts profit outlook after weaker sales of weight-loss drug Wegovy

Danish company, which also makes Ozempic, faces increasing competition from US rival Eli Lilly

The Guardian - UK

1 Billionaire-Backed Penny Stock With 421% Upside

1 Billionaire-Backed Penny Stock With 421% Upside

Down 96% from all-time highs, AbCellera Biologics is a biotech stock with massive upside potential, given consensus price target estimates.

10 Imploding Stocks Cost Investors A Staggering $2.6 Trillion

10 Imploding Stocks Cost Investors A Staggering $2.6 Trillion

The S&P 500 is down "only" 8.2% since its July 16 high. So why does the drop feel so bad?

Investors Business Daily

Dow Jones Futures Dive Amid Global Rout; Nvidia AI Chip Report, Buffett's Apple Move In Focus

Dow Jones Futures Dive Amid Global Rout; Nvidia AI Chip Report, Buffett's Apple Move In Focus

Recession fears are gripping the market. Warren Buffett's Berkshire halved its Apple stake. Nvidia reportedly has delayed its next AI chip.

Investors Business Daily

How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut

How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut

Tirzepatide, a drug for diabetes and obesity, has sent the 148-year-old pharma giant on a wild ride. It’s now the ninth most valuable company in the world.

Should You Buy These Stocks Before They Join The $1 Trillion Market Cap Club?

Should You Buy These Stocks Before They Join The $1 Trillion Market Cap Club?

Their strong fundamentals, brand strength, and drive to succeed could propel their stock higher.

Get all your
news in one place.

100’s of premium titles.
One news app.

3 Healthcare Innovators With Game-Changing Treatments

The pharmaceutical industry’s long-term growth is fueled by a surge in demand for personalized medicine, rising R&D initiatives, and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid pharma stocks, Eli Lilly (LLY), Bristol-Myers (BMY), and Merck & Co. (MRK), which look poised for blockbuster…

3 Leading S&P 500 Stocks Set to Climb Even Higher

As the stock market evolves, leading S&P 500 stocks like Eli Lilly and Company (LLY), Howmet Aerospace (HWM), and NetApp (NTAP) are well-positioned to capitalize on current market conditions and climb higher. Read on….

Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss

Roche is working on bringing its weight-loss medications to patients "faster than anticipated,” making it yet another contender in the weight-loss drug market.

International Business Times UK

Jim Cramer Names Six Companies That May Enter the Trillion-Dollar Stock Club

In a recent episode of CNBC's Mad Money show, Jim Cramer named companies like Eli Lilly, Tesla, JPMorgan, and Walmart that could reach a $1 trillion market valuation.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Viking Therapeutics Unveils Monthly Weight-Loss Shot, Rocking Eli Lilly, Novo Nordisk

Viking Therapeutics stock rocketed Thursday after the company said it's exploring a monthly dose of its weight-loss drug.

Broadcasting & Cable

NBCU Plans Commercial-Free Hour During Olympic Opening Ceremonies

Coca-Cola, Delta, Eli Lilly, Toyota, Visa, Xfinity get ‘brought to you by’ mentions

What You Need to Know Ahead of Eli Lilly's Earnings Release

As Eli Lilly gears up to release its second-quarter earnings next month, analysts project a double-digit bottom-line growth.

Investors Business Daily

Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review

The stock market rally had some wild moves during the week. The Dow Jones and Russell 2000 jumped, but came off highs. The Nasdaq tumbled.

Investors Business Daily

Dow Jones Futures: Netflix Subscribers Jump As Tesla, Nvidia Resilient; President Biden Buzz Heats Up

Stocks retreated Thursday, but Tesla and Nvidia were resilient. Netflix subscribers jumped. President Biden may be close to dropping out, but reports differ.

Investors Business Daily

Dow Jones Futures: Taiwan Semi Lifts Chip Stocks After Nasdaq's Worst Loss Since 2022

Taiwan Semi beat and guided up giving Nvidia and other chip stocks a little lift after the Nasdaq's worst day since 2022.

Investors Business Daily

Eli Lilly, Novo Nordisk — And Their Rivals — Skid On Roche's Weight-Loss Drug Results

Eli Lilly and Novo Nordisk fell Wednesday after Roche released positive early-stage trial data on its oral weight-loss drug.

People

106,661 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

260,528 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play